Collecting and evaluating convalescent plasma for COVID‐19 treatment: why and how?

Positive RT-PCR Test Results in Patients Recovered From COVID-19

(2020) Lan Lan et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

(2020) Roujian Lu et al.   LANCET

Convalescent plasma as a potential therapy for COVID-19

(2020) Long Chen et al.   LANCET INFECTIOUS DISEASES

Covid-19 — Navigating the Uncharted

(2020) Anthony S. Fauci et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical Characteristics of Coronavirus Disease 2019 in China

(2020) Wei-jie Guan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Inactivation of three emerging viruses – severe acute respiratory syndrome coronavirus, Crimean–Congo haemorrhagic fever virus and Nipah virus – in platelet concentrates by ultraviolet C light and in plasma by methylene blue plus visible light

(2020) Markus Eickmann et al.   VOX SANGUINIS

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

(2020) Alexandra C. Walls et al.   CELL

Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma

(2020) Chenguang Shen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The convalescent sera option for containing COVID-19

(2020) Arturo Casadevall et al.   JOURNAL OF CLINICAL INVESTIGATION

Amotosalen and ultraviolet A light efficiently inactivate MERS‐coronavirus in human platelet concentrates

(2019) A. M. Hashem et al.   TRANSFUSION MEDICINE

Combination of ELISA screening and seroneutralisation tests to expedite Zika virus seroprevalence studies

(2018) Elif Nurtop et al.   Virology Journal

We Can Do Better — Improving Outcomes in the Midst of an Emergency

(2017) Lindsey R. Baden et al.   NEW ENGLAND JOURNAL OF MEDICINE

Enhanced inflammation in New Zealand white rabbits when MERS-CoV reinfection occurs in the absence of neutralizing antibody

(2017) Katherine V. Houser et al.   PLoS Pathogens

Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea

(2016) Johan van Griensven et al.   NEW ENGLAND JOURNAL OF MEDICINE

Inactivation of Middle East respiratory syndrome coronavirus (MERS-CoV) in plasma products using a riboflavin-based and ultraviolet light-based photochemical treatment

(2016) Shawn D. Keil et al.   TRANSFUSION

Pathogen-reduced Ebola virus convalescent plasma: first steps towards standardization of manufacturing and quality control including assessment of Ebola-specific neutralizing antibodies

(2016) C. Geisen et al.   VOX SANGUINIS

Possible Transfusion-Related Acute Lung Injury Following Convalescent Plasma Transfusion in a Patient With Middle East Respiratory Syndrome

(2016) Sejong Chun et al.   Annals of Laboratory Medicine

Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates

(2016) Qidi Wang et al.   ACS Infectious Diseases

Fc receptors in antibody-dependent enhancement of viral infections

(2015) Adam Taylor et al.   IMMUNOLOGICAL REVIEWS

Acute respiratory distress syndrome after convalescent plasma use: treatment of a patient with Ebola virus disease contracted in Madrid, Spain

(2015) Marta Mora-Rillo et al.   Lancet Respiratory Medicine

Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins

(2014) Sheng-Fan Wang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis

(2014) John Mair-Jenkins et al.   JOURNAL OF INFECTIOUS DISEASES

Hyperimmune IV Immunoglobulin Treatment

(2013) Ivan F.N. Hung et al.   CHEST

Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus

(2012) Chien-Te Tseng et al.   PLoS One

Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus Infection

(2011) I. F. Hung et al.   CLINICAL INFECTIOUS DISEASES

Longitudinal profiles of immunoglobulin G antibodies against severe acute respiratory syndrome coronavirus components and neutralizing activities in recovered patients

(2011) Lifeng Liu et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES

Effect of Clinical and Virological Parameters on the Level of Neutralizing Antibody against Pandemic Influenza A Virus H1N1 2009

(2010) Ivan F. N. Hung et al.   CLINICAL INFECTIOUS DISEASES

Practical limitations of convalescent plasma collection: a case scenario in pandemic preparation for influenza A (H1N1) infection

(2010) Hoi K. Wong et al.   TRANSFUSION